首页 > 最新文献

Oxford Textbook of Global Public Health最新文献

英文 中文
Natural and quasi-experiments 自然实验和准实验
Pub Date : 2021-11-01 DOI: 10.1093/med/9780198816805.003.0034
P. Craig
Natural experiments, defined as events or processes outwith the control of a researcher, which divide a population into exposed and unexposed groups, have long been used in epidemiology and public health. Evaluation methods that rely on observational rather than experimental data are classified as second best in conventional hierarchies of evidence. Natural experimental approaches have attracted renewed interest from public health researchers and decision-makers because they widen the range of interventions that can usefully be evaluated beyond those that are politically, ethically, or practically amenable to testing in randomized controlled trials. This chapter argues for seeing trials and natural experiments as part of a common toolkit for producers and users of evidence about the effectiveness of policies and programmes. It describes the most commonly used natural experimental approaches to evaluating population health interventions, and provides examples of their use in a wide range of countries and policy settings.
自然实验被定义为在研究人员控制下将人群分为暴露组和未暴露组的事件或过程,长期以来一直用于流行病学和公共卫生。依赖于观测数据而不是实验数据的评估方法在传统的证据等级中被列为次等。自然实验方法重新引起了公共卫生研究人员和决策者的兴趣,因为它们扩大了干预措施的范围,可以有效地评估那些在政治上、道德上或实际上可以在随机对照试验中进行测试的干预措施。本章主张将试验和自然实验视为政策和规划有效性证据的生产者和使用者的共同工具包的一部分。它描述了评价人口健康干预措施最常用的自然实验方法,并提供了在各种国家和政策环境中使用这些方法的实例。
{"title":"Natural and quasi-experiments","authors":"P. Craig","doi":"10.1093/med/9780198816805.003.0034","DOIUrl":"https://doi.org/10.1093/med/9780198816805.003.0034","url":null,"abstract":"Natural experiments, defined as events or processes outwith the control of a researcher, which divide a population into exposed and unexposed groups, have long been used in epidemiology and public health. Evaluation methods that rely on observational rather than experimental data are classified as second best in conventional hierarchies of evidence. Natural experimental approaches have attracted renewed interest from public health researchers and decision-makers because they widen the range of interventions that can usefully be evaluated beyond those that are politically, ethically, or practically amenable to testing in randomized controlled trials. This chapter argues for seeing trials and natural experiments as part of a common toolkit for producers and users of evidence about the effectiveness of policies and programmes. It describes the most commonly used natural experimental approaches to evaluating population health interventions, and provides examples of their use in a wide range of countries and policy settings.","PeriodicalId":206715,"journal":{"name":"Oxford Textbook of Global Public Health","volume":"95 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131350186","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Toxicology and environmental risk analysis 毒理学和环境风险分析
Pub Date : 2021-11-01 DOI: 10.1093/med/9780198816805.003.0056
David Koh, R. Lin
Risk-based decision-making increasingly has global dimensions, extending from the international management of chemical risks to the sustainable development of our planet. Environmental risk analysis is firmly based on toxicological sciences with input from other public health disciplines. Increasing understanding of how the human genotype and phenotype affects absorption, distribution, metabolism, and excretion of xenobiotics (compounds foreign to a living organism), is providing insight into answers to the oldest human question about disease: ‘Why me?’ The risk paradigm components of hazard assessment, dose–analysis, exposure assessment, risk characterization, risk management, and risk communication, and the toxicological concepts on which they are based, have proven durable in approaching increasingly complex environmental hazards. Newer approaches to managing risk, such as the precautionary principle, and newer challenges, such as nanotechnology and genetically modified organisms, necessitate further systematic thinking on how best to protect human health and the environment.
基于风险的决策越来越具有全球影响,从化学品风险的国际管理延伸到我们地球的可持续发展。环境风险分析牢固地以毒理学科学为基础,并得到其他公共卫生学科的投入。对人类基因型和表型如何影响异种生物(生物体的外来化合物)的吸收、分布、代谢和排泄的理解日益加深,为人类最古老的疾病问题提供了答案:“为什么是我?”危害评估、剂量分析、暴露评估、风险表征、风险管理和风险沟通的风险范式组成部分,以及它们所基于的毒理学概念,在处理日益复杂的环境危害方面已被证明是持久的。管理风险的新方法,如预防原则,以及新的挑战,如纳米技术和转基因生物,都需要进一步系统地思考如何最好地保护人类健康和环境。
{"title":"Toxicology and environmental risk analysis","authors":"David Koh, R. Lin","doi":"10.1093/med/9780198816805.003.0056","DOIUrl":"https://doi.org/10.1093/med/9780198816805.003.0056","url":null,"abstract":"Risk-based decision-making increasingly has global dimensions, extending from the international management of chemical risks to the sustainable development of our planet. Environmental risk analysis is firmly based on toxicological sciences with input from other public health disciplines. Increasing understanding of how the human genotype and phenotype affects absorption, distribution, metabolism, and excretion of xenobiotics (compounds foreign to a living organism), is providing insight into answers to the oldest human question about disease: ‘Why me?’ The risk paradigm components of hazard assessment, dose–analysis, exposure assessment, risk characterization, risk management, and risk communication, and the toxicological concepts on which they are based, have proven durable in approaching increasingly complex environmental hazards. Newer approaches to managing risk, such as the precautionary principle, and newer challenges, such as nanotechnology and genetically modified organisms, necessitate further systematic thinking on how best to protect human health and the environment.","PeriodicalId":206715,"journal":{"name":"Oxford Textbook of Global Public Health","volume":"155 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134401556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Case–control studies 病例对照研究
Pub Date : 2021-11-01 DOI: 10.1093/med/9780199661756.003.0107
N. Weiss, R. Detels, R. Beaglehole, M. Lansing, M. Gulliford
Case–control studies compare ill or injured individuals (cases) with those at risk of the illness or injury (controls) with regard to prior exposures or characteristics, and so appear to proceed backwards, from consequence to potential cause. They have the potential to identify associations that are not causal, either because of chance, or because of the influence of some other factor associated with both the exposure and outcome. However, if a case–control study is able to enrol cases and controls from the same underlying population at risk of the outcome, and can measure exposure status of these persons in a valid manner, the results obtained will closely resemble those of a properly performed cohort study.
病例对照研究将患病或受伤的个体(病例)与有患病或受伤风险的个体(对照)就先前的暴露或特征进行比较,因此似乎是从后果到潜在原因进行反向研究。它们有可能识别出非因果关系的关联,这些关联要么是偶然的,要么是与暴露和结果相关的其他因素的影响。然而,如果一项病例对照研究能够从同一潜在风险人群中纳入病例和对照,并能够以有效的方式测量这些人的暴露状况,则获得的结果将与正确执行的队列研究的结果非常相似。
{"title":"Case–control studies","authors":"N. Weiss, R. Detels, R. Beaglehole, M. Lansing, M. Gulliford","doi":"10.1093/med/9780199661756.003.0107","DOIUrl":"https://doi.org/10.1093/med/9780199661756.003.0107","url":null,"abstract":"Case–control studies compare ill or injured individuals (cases) with those at risk of the illness or injury (controls) with regard to prior exposures or characteristics, and so appear to proceed backwards, from consequence to potential cause. They have the potential to identify associations that are not causal, either because of chance, or because of the influence of some other factor associated with both the exposure and outcome. However, if a case–control study is able to enrol cases and controls from the same underlying population at risk of the outcome, and can measure exposure status of these persons in a valid manner, the results obtained will closely resemble those of a properly performed cohort study.","PeriodicalId":206715,"journal":{"name":"Oxford Textbook of Global Public Health","volume":"56 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133743238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The history and development of public health in developed countries 发达国家公共卫生的历史与发展
Pub Date : 2021-11-01 DOI: 10.1093/med/9780198816805.003.0002
S. Szreter
It has been conventional to locate the origins of public health in early efforts to combat epidemics and to regulate the sanitary environment accompanying urban life and to trace its history in the gradual evolution of such measures in relation to politics, administrative practices, public laws, and medical science’s changing aetiology. Such an historical account provides important insights and understanding but it is also de-limited in one significant sense. Public health is cast in a responsive role in relation to the processes of economic development. However, the nature of the relationship between public health and global economic development can appear very differently when it is viewed over the long-term, encompassing the whole process of modern economic transformation from the singular matrix of its origins in the early modern society and economy of England, c.1600–1800. This chapter will show that state policies to promote the social order, security, and health of the population in fact pre-date and crucially underpinned the process through which the modern world’s economic transformation originated—in early modern England.
人们通常将公共卫生的起源定位于早期抗击流行病和规范城市生活所伴随的卫生环境的努力,并在这些措施与政治、行政实践、公法和医学不断变化的病因学相关的逐渐演变中追溯其历史。这样的历史叙述提供了重要的见解和理解,但在一个重要的意义上,它也被限制了。公共卫生在经济发展进程中发挥了响应作用。然而,从长期来看,公共卫生与全球经济发展之间关系的性质可能会出现非常不同的情况,包括现代经济转型的整个过程,其起源是英国早期现代社会和经济(1600 - 1800年)的单一矩阵。本章将表明,促进社会秩序、安全和人口健康的国家政策实际上早于现代世界经济转型起源的过程,并至关重要地支撑了这一过程——在近代早期的英国。
{"title":"The history and development of public health in developed countries","authors":"S. Szreter","doi":"10.1093/med/9780198816805.003.0002","DOIUrl":"https://doi.org/10.1093/med/9780198816805.003.0002","url":null,"abstract":"It has been conventional to locate the origins of public health in early efforts to combat epidemics and to regulate the sanitary environment accompanying urban life and to trace its history in the gradual evolution of such measures in relation to politics, administrative practices, public laws, and medical science’s changing aetiology. Such an historical account provides important insights and understanding but it is also de-limited in one significant sense. Public health is cast in a responsive role in relation to the processes of economic development. However, the nature of the relationship between public health and global economic development can appear very differently when it is viewed over the long-term, encompassing the whole process of modern economic transformation from the singular matrix of its origins in the early modern society and economy of England, c.1600–1800. This chapter will show that state policies to promote the social order, security, and health of the population in fact pre-date and crucially underpinned the process through which the modern world’s economic transformation originated—in early modern England.","PeriodicalId":206715,"journal":{"name":"Oxford Textbook of Global Public Health","volume":"27 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133840291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Socioeconomic inequalities in health in high-income countries 高收入国家卫生方面的社会经济不平等
Pub Date : 2021-11-01 DOI: 10.1093/med/9780198816805.003.0009
F. Lenthe, J. Mackenbach
Socioeconomic inequalities in health have been studied extensively in the past decades. In all high-income countries with available data, mortality and morbidity rates are higher among those in less advantaged socioeconomic positions, and as a result differences in health expectancy between socioeconomic groups typically amount to 10 years or more. Good progress has been made in unravelling the determinants of health inequalities, and a number of specific determinants (particularly material, psychosocial, and lifestyle factors) have been identified which contribute to explaining health inequalities in many high-income countries. Although further research is necessary, our understanding of what causes health inequalities has progressed to a stage where rational approaches to reduce health inequalities are becoming feasible. Evidence of a reduction of health inequalities via interventions and policies based on the underlying causes remains scarce, and point to a need to increase efforts.
过去几十年来,人们对健康方面的社会经济不平等现象进行了广泛研究。在所有有现有数据的高收入国家中,处于较不利社会经济地位的人的死亡率和发病率较高,因此,社会经济群体之间的健康预期差异通常达到10年或更长时间。在揭示健康不平等的决定因素方面取得了良好进展,并确定了一些具体的决定因素(特别是物质、社会心理和生活方式因素),这些因素有助于解释许多高收入国家的健康不平等。虽然需要进一步的研究,但我们对造成健康不平等的原因的理解已经发展到减少健康不平等的合理方法变得可行的阶段。通过基于根本原因的干预措施和政策减少卫生不平等现象的证据仍然很少,这表明需要加大努力。
{"title":"Socioeconomic inequalities in health in high-income countries","authors":"F. Lenthe, J. Mackenbach","doi":"10.1093/med/9780198816805.003.0009","DOIUrl":"https://doi.org/10.1093/med/9780198816805.003.0009","url":null,"abstract":"Socioeconomic inequalities in health have been studied extensively in the past decades. In all high-income countries with available data, mortality and morbidity rates are higher among those in less advantaged socioeconomic positions, and as a result differences in health expectancy between socioeconomic groups typically amount to 10 years or more. Good progress has been made in unravelling the determinants of health inequalities, and a number of specific determinants (particularly material, psychosocial, and lifestyle factors) have been identified which contribute to explaining health inequalities in many high-income countries. Although further research is necessary, our understanding of what causes health inequalities has progressed to a stage where rational approaches to reduce health inequalities are becoming feasible. Evidence of a reduction of health inequalities via interventions and policies based on the underlying causes remains scarce, and point to a need to increase efforts.","PeriodicalId":206715,"journal":{"name":"Oxford Textbook of Global Public Health","volume":"94 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124044380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Validity and bias in epidemiological research 流行病学研究的有效性和偏倚
Pub Date : 2021-11-01 DOI: 10.1093/med/9780198816805.003.0036
S. Greenland, T. VanderWeele
Some of the major concepts of validity and bias in epidemiological research are outlined in this chapter. The contents are organized in four main sections: Validity in statistical interpretation, validity in prediction problems, validity in causal inference, and special validity problems in case–control and retrospective cohort studies. Familiarity with the basics of epidemiological study design and a number of terms of epidemiological theory, among them risk, competing risks, average risk, population at risk, and rate, is assumed. Despite similarities, there is considerable diversity and conflict among the classification schemes and terminologies employed in various textbooks. This diversity reflects that there is no unique way of classifying validity conditions, biases, and errors. It follows that the classification schemes employed here and elsewhere should not be regarded as anything more than convenient frameworks for organizing discussions of validity and bias in epidemiological inference. Several important study designs, including randomized trials, prevalence (cross-sectional) studies, and ecological studies, are not discussed in this chapter. Such studies require consideration of the validity conditions mentioned earlier and also require special considerations of their own. A number of central problems of epidemiological inference are also not covered, including choice of effect measures, problems of induction, and causal modelling.
本章概述了流行病学研究中效度和偏倚的一些主要概念。内容分为四个主要部分:统计解释的效度、预测问题的效度、因果推理的效度以及病例对照和回顾性队列研究的特殊效度问题。假定熟悉流行病学研究设计的基础知识和流行病学理论的一些术语,其中包括风险、竞争风险、平均风险、处于风险中的人口和比率。尽管有相似之处,但在各种教科书中使用的分类方案和术语之间存在相当大的差异和冲突。这种多样性反映了没有唯一的方法来分类有效性条件、偏差和错误。因此,这里和其他地方采用的分类方案不应被视为组织讨论流行病学推断的有效性和偏差的方便框架。几个重要的研究设计,包括随机试验、流行(横断面)研究和生态学研究,在本章中没有讨论。这类研究需要考虑前面提到的有效性条件,也需要它们自己的特殊考虑。流行病学推断的一些核心问题也没有涉及,包括效果度量的选择、归纳问题和因果建模。
{"title":"Validity and bias in epidemiological research","authors":"S. Greenland, T. VanderWeele","doi":"10.1093/med/9780198816805.003.0036","DOIUrl":"https://doi.org/10.1093/med/9780198816805.003.0036","url":null,"abstract":"Some of the major concepts of validity and bias in epidemiological research are outlined in this chapter. The contents are organized in four main sections: Validity in statistical interpretation, validity in prediction problems, validity in causal inference, and special validity problems in case–control and retrospective cohort studies. Familiarity with the basics of epidemiological study design and a number of terms of epidemiological theory, among them risk, competing risks, average risk, population at risk, and rate, is assumed. Despite similarities, there is considerable diversity and conflict among the classification schemes and terminologies employed in various textbooks. This diversity reflects that there is no unique way of classifying validity conditions, biases, and errors. It follows that the classification schemes employed here and elsewhere should not be regarded as anything more than convenient frameworks for organizing discussions of validity and bias in epidemiological inference. Several important study designs, including randomized trials, prevalence (cross-sectional) studies, and ecological studies, are not discussed in this chapter. Such studies require consideration of the validity conditions mentioned earlier and also require special considerations of their own. A number of central problems of epidemiological inference are also not covered, including choice of effect measures, problems of induction, and causal modelling.","PeriodicalId":206715,"journal":{"name":"Oxford Textbook of Global Public Health","volume":"30 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128154010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Poverty, justice, and health 贫穷,正义和健康
Pub Date : 2021-11-01 DOI: 10.1093/med/9780198816805.003.0008
R. Labonté, F. Baum, D. Sanders
Poverty has long been a concern in public health with people living in poor circumstances generally suffering higher burdens of disease. Understanding the persistence of poverty, and of its impacts on health, unavoidably intersects with analyses of how inequalities arise in the distribution of income and wealth, and of the material and psychosocial resources these socioeconomic privileges accord. This chapter reviews different definitions of poverty, trends in the distribution of absolute and relative poverty, and strengths and weaknesses of the different concepts. It touches briefly on how poverty (by whatever definition) influences health, citing natural/social selection, cultural/behavioural, and materialist/structural explanations; and discusses how, in some instances, there is reverse causality with poor health worsening individual or household poverty, particularly in low-income countries suffering high disease burdens and weak health systems. The chapter then turns to a review of major theories of justice and how these argue for interventions, and the role that international human rights might play in furthering actions to reduce poverty-related health inequalities. It concludes with a short discussion of different sociopolitical approaches to poverty reduction, providing three examples of intervention policies.
贫困长期以来一直是公共卫生领域的一个关切问题,生活在贫困环境中的人通常承受着更高的疾病负担。了解贫困的持续存在及其对健康的影响,不可避免地与分析收入和财富分配中的不平等如何产生,以及这些社会经济特权所赋予的物质和社会心理资源相交。本章回顾了贫穷的不同定义,绝对和相对贫穷的分布趋势,以及不同概念的优缺点。它简要介绍了贫穷(无论如何定义)如何影响健康,并引用了自然/社会选择、文化/行为和唯物主义/结构的解释;并讨论了在某些情况下,特别是在疾病负担高和卫生系统薄弱的低收入国家,健康状况不佳与个人或家庭贫困如何存在反向因果关系。然后,本章转向审查主要的司法理论,以及这些理论如何支持干预措施,以及国际人权在进一步采取行动减少与贫困有关的卫生不平等方面可能发挥的作用。报告最后简要讨论了减少贫困的不同社会政治方法,并提供了三个干预政策的例子。
{"title":"Poverty, justice, and health","authors":"R. Labonté, F. Baum, D. Sanders","doi":"10.1093/med/9780198816805.003.0008","DOIUrl":"https://doi.org/10.1093/med/9780198816805.003.0008","url":null,"abstract":"Poverty has long been a concern in public health with people living in poor circumstances generally suffering higher burdens of disease. Understanding the persistence of poverty, and of its impacts on health, unavoidably intersects with analyses of how inequalities arise in the distribution of income and wealth, and of the material and psychosocial resources these socioeconomic privileges accord. This chapter reviews different definitions of poverty, trends in the distribution of absolute and relative poverty, and strengths and weaknesses of the different concepts. It touches briefly on how poverty (by whatever definition) influences health, citing natural/social selection, cultural/behavioural, and materialist/structural explanations; and discusses how, in some instances, there is reverse causality with poor health worsening individual or household poverty, particularly in low-income countries suffering high disease burdens and weak health systems. The chapter then turns to a review of major theories of justice and how these argue for interventions, and the role that international human rights might play in furthering actions to reduce poverty-related health inequalities. It concludes with a short discussion of different sociopolitical approaches to poverty reduction, providing three examples of intervention policies.","PeriodicalId":206715,"journal":{"name":"Oxford Textbook of Global Public Health","volume":"15 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129297656","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ethical principles and ethical issues in public health 公共卫生中的伦理原则和伦理问题
Pub Date : 2021-11-01 DOI: 10.1093/med/9780199218707.003.0022
N. Kass
Public health ethics considers moral dimensions of public health practice and research. While medical ethics dates back hundreds of years, and bioethics writings emerged in the 1960s and 1970s, ‘public health ethics’, articulated as such, did not appear significantly in the literature for several more decades. There has been great interest recently in defining public health ethics, examining how it resembles or differs from medical ethics or bioethics, outlining frameworks and codes, and providing conceptual and practical guidance on how ethics can inform public health practice and research. This chapter describes the emergence of public health ethics; work in bioethics with relevance for public health; the relevance of social justice theory in addressing public health problems; and discusses literature on ethics and public health research, including whether public health research ethics might differ from ethical guidance for other human research. The chapter concludes with an overview of ethics issues related to genetic research and emerging technologies.
公共卫生伦理学考虑公共卫生实践和研究的道德层面。虽然医学伦理学可以追溯到几百年前,生物伦理学著作出现在20世纪60年代和70年代,但“公共卫生伦理学”,这样的表述,在几十年后才在文献中出现。最近,人们对界定公共卫生伦理、研究它与医学伦理或生物伦理的相似或不同之处、概述框架和准则以及就伦理如何为公共卫生实践和研究提供概念和实践指导等方面的工作非常感兴趣。本章描述了公共卫生伦理的出现;与公共卫生相关的生物伦理学工作;社会正义理论在解决公共卫生问题中的相关性;并讨论了关于伦理和公共卫生研究的文献,包括公共卫生研究伦理是否可能不同于其他人类研究的伦理指导。本章最后概述了与基因研究和新兴技术相关的伦理问题。
{"title":"Ethical principles and ethical issues in public health","authors":"N. Kass","doi":"10.1093/med/9780199218707.003.0022","DOIUrl":"https://doi.org/10.1093/med/9780199218707.003.0022","url":null,"abstract":"Public health ethics considers moral dimensions of public health practice and research. While medical ethics dates back hundreds of years, and bioethics writings emerged in the 1960s and 1970s, ‘public health ethics’, articulated as such, did not appear significantly in the literature for several more decades. There has been great interest recently in defining public health ethics, examining how it resembles or differs from medical ethics or bioethics, outlining frameworks and codes, and providing conceptual and practical guidance on how ethics can inform public health practice and research. This chapter describes the emergence of public health ethics; work in bioethics with relevance for public health; the relevance of social justice theory in addressing public health problems; and discusses literature on ethics and public health research, including whether public health research ethics might differ from ethical guidance for other human research. The chapter concludes with an overview of ethics issues related to genetic research and emerging technologies.","PeriodicalId":206715,"journal":{"name":"Oxford Textbook of Global Public Health","volume":"161 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127292223","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Life course epidemiology and analysis 生命历程流行病学与分析
Pub Date : 2021-11-01 DOI: 10.1093/med/9780198816805.003.0043
Elizabeth Rose Mayeda, Alexandra M. Binder, L. Kobayashi
Life course epidemiology approaches disease aetiology and prevention from the perspective of risk and protective factors that influence health and disease throughout the lifespan. The integration of a life course approach to epidemiologic research is central for identifying effective policies and programmes to promote population health and health equity. This chapter will introduce life course concepts and models and analytical approaches for research on life course determinants of health. It will discuss threats to causal inference, approaches for overcoming these difficulties, and future directions in life course epidemiology. For example, in addition to expanding epidemiologic research with a life course perspective to include people with diverse life experiences, new areas of development include life course research extending beyond one human lifespan to include intergenerational and transgenerational life course research, as well as the application of innovative methods.
生命过程流行病学从影响整个生命周期的健康和疾病的风险和保护因素的角度来研究疾病的病因学和预防。将生命历程方法纳入流行病学研究是确定促进人口健康和保健公平的有效政策和方案的核心。本章将介绍生命过程的概念和模型以及研究健康的生命过程决定因素的分析方法。它将讨论对因果推理的威胁,克服这些困难的方法,以及生命过程流行病学的未来方向。例如,除了从生命历程的角度扩大流行病学研究,使其包括具有不同生活经历的人之外,新的发展领域还包括超越一个人的寿命的生命历程研究,包括代际和跨代生命历程研究,以及创新方法的应用。
{"title":"Life course epidemiology and analysis","authors":"Elizabeth Rose Mayeda, Alexandra M. Binder, L. Kobayashi","doi":"10.1093/med/9780198816805.003.0043","DOIUrl":"https://doi.org/10.1093/med/9780198816805.003.0043","url":null,"abstract":"Life course epidemiology approaches disease aetiology and prevention from the perspective of risk and protective factors that influence health and disease throughout the lifespan. The integration of a life course approach to epidemiologic research is central for identifying effective policies and programmes to promote population health and health equity. This chapter will introduce life course concepts and models and analytical approaches for research on life course determinants of health. It will discuss threats to causal inference, approaches for overcoming these difficulties, and future directions in life course epidemiology. For example, in addition to expanding epidemiologic research with a life course perspective to include people with diverse life experiences, new areas of development include life course research extending beyond one human lifespan to include intergenerational and transgenerational life course research, as well as the application of innovative methods.","PeriodicalId":206715,"journal":{"name":"Oxford Textbook of Global Public Health","volume":"21 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115453985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Economic appraisal in public healthcare: assessing efficiency and equity 公共医疗保健的经济评估:评估效率和公平性
Pub Date : 2015-02-01 DOI: 10.1093/MED/9780199661756.003.0129
D. Parkin, S. Morris, N. Devlin
This chapter is an introduction to economic appraisal. It explains underlying concepts, describes methods used, and discusses the application to public health. Economic appraisal comprises techniques that weigh up the costs of an action, such as providing a public health intervention to an at-risk population group, against the benefits that it provides. Important underlying principles are opportunity cost, social versus private costs and benefits, marginal costs and benefits, efficiency, and equity. There are different types of economic appraisal, each of which measures the costs and benefits of options being compared. Measuring costs involves identifying and describing resource use changes, quantifying them in physical units and valuing them. Issues in cost measurement include use of macro or micro-costing and dealing with inflation and time preference. There are several approaches that can be used to measure benefits depending on the type of economic appraisal being used; a measure of special interest is quality-adjusted life years (QALYs). Modelling is often used in economic appraisal to combine data on the costs and benefits of an intervention. Given the inherent uncertainties involved in economic appraisal it is good practice to undertake sensitivity analyses that investigate the impact of uncertainty. Methodological challenges in undertaking economic appraisals of public health interventions include the importance of equity and inequality considerations, establishing robust evidence of the effect of public health programmes, the relevance of QALYs, and accounting for multisectoral costs and benefits.
本章是对经济评价的介绍。它解释了基本概念,描述了使用的方法,并讨论了公共卫生的应用。经济评估包括权衡一项行动的成本(例如向高危人群提供公共卫生干预)与其带来的利益的技术。重要的基本原则是机会成本、社会与私人的成本和收益、边际成本和收益、效率和公平。有不同类型的经济评估,每一种都衡量被比较选项的成本和收益。衡量成本包括识别和描述资源使用的变化,以物理单位对其进行量化,并对其进行估价。成本计量中的问题包括使用宏观或微观成本核算,以及处理通货膨胀和时间偏好。根据所使用的经济评估的类型,有几种方法可用于衡量效益;一个特别有趣的测量方法是质量调整生命年(QALYs)。建模通常用于经济评估,以结合干预的成本和收益的数据。考虑到经济评估中所涉及的固有不确定性,进行敏感性分析以调查不确定性的影响是一种很好的做法。在对公共卫生干预措施进行经济评估时,方法上的挑战包括必须考虑到公平和不平等问题,确定公共卫生规划效果的有力证据,质量评估年的相关性,以及对多部门成本和效益的核算。
{"title":"Economic appraisal in public healthcare: assessing efficiency and equity","authors":"D. Parkin, S. Morris, N. Devlin","doi":"10.1093/MED/9780199661756.003.0129","DOIUrl":"https://doi.org/10.1093/MED/9780199661756.003.0129","url":null,"abstract":"This chapter is an introduction to economic appraisal. It explains underlying concepts, describes methods used, and discusses the application to public health. Economic appraisal comprises techniques that weigh up the costs of an action, such as providing a public health intervention to an at-risk population group, against the benefits that it provides. Important underlying principles are opportunity cost, social versus private costs and benefits, marginal costs and benefits, efficiency, and equity. There are different types of economic appraisal, each of which measures the costs and benefits of options being compared. Measuring costs involves identifying and describing resource use changes, quantifying them in physical units and valuing them. Issues in cost measurement include use of macro or micro-costing and dealing with inflation and time preference. There are several approaches that can be used to measure benefits depending on the type of economic appraisal being used; a measure of special interest is quality-adjusted life years (QALYs). Modelling is often used in economic appraisal to combine data on the costs and benefits of an intervention. Given the inherent uncertainties involved in economic appraisal it is good practice to undertake sensitivity analyses that investigate the impact of uncertainty. Methodological challenges in undertaking economic appraisals of public health interventions include the importance of equity and inequality considerations, establishing robust evidence of the effect of public health programmes, the relevance of QALYs, and accounting for multisectoral costs and benefits.","PeriodicalId":206715,"journal":{"name":"Oxford Textbook of Global Public Health","volume":"88 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2015-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126761457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
期刊
Oxford Textbook of Global Public Health
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1